1. Home
  2. EFT vs SLP Comparison

EFT vs SLP Comparison

Compare EFT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFT
  • SLP
  • Stock Information
  • Founded
  • EFT 2004
  • SLP 1996
  • Country
  • EFT United States
  • SLP United States
  • Employees
  • EFT N/A
  • SLP N/A
  • Industry
  • EFT Finance Companies
  • SLP EDP Services
  • Sector
  • EFT Finance
  • SLP Technology
  • Exchange
  • EFT Nasdaq
  • SLP Nasdaq
  • Market Cap
  • EFT 327.7M
  • SLP 282.4M
  • IPO Year
  • EFT N/A
  • SLP 1997
  • Fundamental
  • Price
  • EFT $11.96
  • SLP $15.44
  • Analyst Decision
  • EFT
  • SLP Buy
  • Analyst Count
  • EFT 0
  • SLP 7
  • Target Price
  • EFT N/A
  • SLP $29.50
  • AVG Volume (30 Days)
  • EFT 100.8K
  • SLP 417.0K
  • Earning Date
  • EFT 01-01-0001
  • SLP 10-22-2025
  • Dividend Yield
  • EFT 10.63%
  • SLP N/A
  • EPS Growth
  • EFT N/A
  • SLP N/A
  • EPS
  • EFT 1.73
  • SLP N/A
  • Revenue
  • EFT N/A
  • SLP $80,383,000.00
  • Revenue This Year
  • EFT N/A
  • SLP $12.75
  • Revenue Next Year
  • EFT N/A
  • SLP $3.06
  • P/E Ratio
  • EFT $7.62
  • SLP N/A
  • Revenue Growth
  • EFT N/A
  • SLP 20.01
  • 52 Week Low
  • EFT $11.10
  • SLP $12.39
  • 52 Week High
  • EFT $13.44
  • SLP $37.67
  • Technical
  • Relative Strength Index (RSI)
  • EFT 31.03
  • SLP 53.04
  • Support Level
  • EFT $11.89
  • SLP N/A
  • Resistance Level
  • EFT $12.05
  • SLP $15.07
  • Average True Range (ATR)
  • EFT 0.13
  • SLP 0.54
  • MACD
  • EFT -0.00
  • SLP -0.37
  • Stochastic Oscillator
  • EFT 69.42
  • SLP 99.26

About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest

Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: